Targeting Tumor Necrosis Factor Pathways in Psoriatic Diseases: The Next Step

Preclinical models suggest that specific blockade of TNFR2 may significantly reduce inflammation and ameliorate signs of psoriatic diseases, while maintaining normal immune response in the host, including the ability to combat infection and cancer. In this article, M. Elaine Husni, MD, MPH, highlights her latest research and discusses her plans to use her new R01 grant to continue her translational work.

Advertising Policy

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy

Advances in the Treatment of Knee Osteoarthritis

Orthopaedic surgeons at Cleveland Clinic will perform the first prospective, double-blind, randomized, placebo-controlled, multicenter feasibility study to examine the safety and efficacy of pulsed electromagnetic fields knee braces in the treatment of knee osteoarthritis.

Advertising Policy